Bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as the second-line therapy for patients with metastatic colorectal cancer, a multicenter study
Titel:
Bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as the second-line therapy for patients with metastatic colorectal cancer, a multicenter study
Auteur:
Deng, Ting Zhang, Le Liu, Xiao-jian Xu, Jian-ming Bai, Yu-xian Wang, Yan Han, Yu Li, Yu-hong Ba, Yi